Mammotome nelle notizie
Rimani informato sulle novità e le tendenze del settore
Comunicati stampa
Mammotome Expands Access to Innovative Breast Biopsy Site Marker
Securing this CE mark expands access to the HydroMARK™ Plus markers across Europe, combining proprietary hydrogel technology with features designed to support marker stability and visibility in breast care.
Mammotome, a Danaher company and global leader in breast care innovation, has obtained a CE mark for the HydroMARK™ Plus Breast Biopsy Site Marker, scaling access to the innovative marker technology across Europe for patients undergoing breast cancer diagnosis and treatment.
Mammotome Launches First In-Room MR Vacuum-Assisted Breast Biopsy System
Mammotome, a Danaher company, announces the Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System, the industry’s first system designed to be positioned in the MRI scanner room, at the patient’s side during a breast biopsy procedure.
Mammotome Celebrates 30 Years of Advancing Breast Care Innovation and Impact
Mammotome proudly celebrates its 30th anniversary – marking three decades of innovation, compassion and unwavering commitment to improving outcomes for patients and clinicians worldwide.
Mammotome and Sirius Medical Expand Partnership for Distribution of the Pintuition® System Across Italy and Poland
Mammotome, a globally recognized leader in breast care, and Sirius Medical, a pioneer of Surgical Marker Navigation, are proud to announce an exclusive distribution agreement for the Pintuition® System in Italy and Poland.
Mammotome Launches the First Vacuum-Assisted Breast Biopsy System Designed for Lesion Excision
Mammotome, a global leader in breast care and the pioneer of vacuum-assisted breast biopsy, is pleased to introduce the Mammotome RevolveTM EX Dual Vacuum-Assisted Breast Biopsy System.